What Your Customers Really Think About Your Xarelto Lawsuit?

//What Your Customers Really Think About Your Xarelto Lawsuit?

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, which includes the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use – and failure to accomplish so may be grounds for compensation. Our lawyers are working hard to acquire these hurt by the drug the compensation they are entitled to.

coumadin blood thinner lawsuitAlthough bleeding can be a widespread complication related with anticoagulants, it has been alleged that Xarelto is much more unsafe than traditional blood thinners because no antidote exists to reverse its blood-thinning side effects xarelto. This indicates that, inside the occasion of an emergency, patients may be at danger for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.

Should you or possibly a loved one suffered a significant bleeding occasion following taking Xarelto, you might have legal recourse. For far more info, make contact with us right now to have your case reviewed, totally free of charge.

Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in cases of death, funeral expenses. Additionally, they may be in search of punitive damages, which are usually awarded to punish the defendant and deter other firms from acting similarly.

Why Are Lawsuits Getting Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.

The makers of the drug continue to market Xarelto as a secure anticoagulant option.

Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.

Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.

Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for a lot more details on the alleged health risks of Xarelto.

Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.